Loading...
Market
Ex-McKinsey partner guilty plea for obstruction by March 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Court records and official announcements from the judicial system
Story
FBI Boston: McKinsey to Pay $650 Million to Settle U.S. Opioid Probe Linked to Purdue Pharma on December 13, 2024
Dec 13, 2024, 02:18 PM
McKinsey & Company has agreed to pay $650 million to settle a U.S. Department of Justice investigation into its advisory role in promoting opioid sales, specifically for Purdue Pharma, the manufacturer of OxyContin. This settlement resolves both criminal and civil investigations into the consulting firm's actions, which have been linked to the opioid epidemic in the United States. The announcement was made during a news conference held by the FBI in Boston, where details about the resolution of these investigations were shared. Additionally, an ex-partner of McKinsey is expected to plead guilty to obstruction as part of the settlement.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Guilty plea and sentencing • 25%
Not guilty verdict • 25%
Case dismissed • 25%
Ongoing legal proceedings • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Settlement finalized with over $500 million • 25%
Settlement finalized with exactly $500 million • 25%
Settlement finalized with less than $500 million • 25%
No settlement finalized by end of 2024 • 25%
No wrongdoing found • 25%
Minor violations identified • 25%
Major violations identified • 25%
Investigation inconclusive • 25%